Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cortes

Showing results (241-250 of 305) with videos related to

Pageof 31
Sort By:
Biochemical and Biophysical Research Communications|December 7, 2005
Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytesHernando Curtidor, Marisol Ocampo, Luis E Rodríguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsJ-C Soria, J Cortes, C Massard, et al.
British Journal of Cancer|January 28, 2015
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignanciesA Spreafico, J-P Delord, L De Mattos-Arruda, et al.
Cell Reports|April 22, 2014
Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophyAndrew P Lieberman, Zhigang Yu, Sue Murray, et al.
British Journal of Cancer|July 11, 2002
Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancerJ Cortes, J Rodriguez, J A Diaz-Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Nature Neuroscience|August 11, 2014
Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMAConstanza J Cortes, Helen C Miranda, Harald Frankowski, et al.
Cancer|November 7, 2000
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemiaS Faderl, H M Kantarjian, E Estey, et al.
Leukemia|November 26, 2013
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agentsH Yang, C Bueso-Ramos, C DiNardo, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Pageof 31

Showing results (241-250 of 305) with videos related to

Sort By:
Pageof 31
Biochemical and Biophysical Research Communications|December 7, 2005
Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytesHernando Curtidor, Marisol Ocampo, Luis E Rodríguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsJ-C Soria, J Cortes, C Massard, et al.
British Journal of Cancer|January 28, 2015
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignanciesA Spreafico, J-P Delord, L De Mattos-Arruda, et al.
Cell Reports|April 22, 2014
Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophyAndrew P Lieberman, Zhigang Yu, Sue Murray, et al.
British Journal of Cancer|July 11, 2002
Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancerJ Cortes, J Rodriguez, J A Diaz-Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Nature Neuroscience|August 11, 2014
Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMAConstanza J Cortes, Helen C Miranda, Harald Frankowski, et al.
Cancer|November 7, 2000
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemiaS Faderl, H M Kantarjian, E Estey, et al.
Leukemia|November 26, 2013
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agentsH Yang, C Bueso-Ramos, C DiNardo, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Pageof 31